BioNexus Gene Lab
BGLC
$0.59
Share price
-0.84%
Change (1 day)
136.00%
Change (1 year)
Categories
EPS for BioNexus Gene Lab (BGLC)
EPS in 2023 (TTM): -$0.04542
According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is -$0.04542. In 2022 the company made an earnings per share (EPS) of -$0.02394 a decrease over its 2021 EPS that were of $0.03626.
EPS history for BioNexus Gene Lab from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.04542 | 89.75% |
| 2022 | -$0.02394 | -166.02% |
| 2021 | $0.03626 | -74.82% |
| 2020 | $0.14 | -600.17% |
| 2019 | -$0.02879 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 4,699.33% | 🇺🇸 USA |